Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Oct;44(7):740-746.
doi: 10.1111/ced.14041. Epub 2019 Aug 4.

Pemphigus vulgaris and pemphigus foliaceus: an overview of the clinical presentation, investigations and management

V Melchionda  1 , K E Harman  1
Affiliations
Review

Pemphigus vulgaris and pemphigus foliaceus: an overview of the clinical presentation, investigations and management

V Melchionda et al. Clin Exp Dermatol. 2019 Oct.

Abstract

Pemphigus diseases are cutaneous and mucous membrane blistering diseases, related to the key antigens of desmoglein 1 and 3. This article reviews the topic, including diagnosis, and provides the physician with guidance on the treatment of these difficult to control disorders.

PubMed Disclaimer

References

    1. Bystryn JC, Steinman NM. The adjuvant therapy of pemphigus. An update. Arch Dermatol 1996; 132: 203-12.
    1. Sirois DA, Fatahzadeh M, Roth R, et al. Diagnostic patterns and delays in pemphigus vulgaris: experience with 99 patients. Arch Dermatol 2000; 136: 1569-70.
    1. International Pemphigus and Pemphigoid Foundation (IPPF). Awareness program. Available at: http://www.pemphigus.org/awareness/about-the-awareness-campaign/campaign...
    1. Harman KE, Brown D, Exton LS, et al. British Association of Dermatologists’ guidelines for the management of pemphigus vulgaris. Br J Dermatol 2017; 177: 1170-1201.
    1. Harman KE, Seed PT, Gratian MJ, et al. The severity of cutaneous and oral pemphigus is related to desmoglein 1 and 3 antibody levels. Br J Dermatol 2001; 144: 775-80.